All posts by: Michael Zand

About Michael Zand

Mesenchymal Stem Cell Infusion a Possible Therapy for Crohn’s Fistulas, Review Study Suggests – IBD News Today

Continue reading

2017-09-27 NEWS

IBD News Today

Mesenchymal Stem Cell Infusion a Possible Therapy for Crohn’s Fistulas, Review Study Suggests
IBD News Today
Given this, Crohn’s disease patients need alternative therapy options. “Stemcell therapies have recently been proposed as a method to address the challenges and prospective medical needs of Crohn’s disease patients in general and those with fistulas

Continue reading

2017-09-27 NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Moving Today – Down $0.85
First News 24
CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular …

and more »